Abstract
Abstract:
A high prevalence of prescribing potentially inappropriate medications, particularly medications with anticholinergic properties (MAP), has been observed in older adults (>65 years of age) with dementia in New Zealand. MAP have been associated with several adverse outcomes in this vulnerable population, specifically the risk of accelerating cognitive decline in patients with pre-existing dementia.
The purpose of this study was to compile a comprehensive list of therapeutic alternatives to MAP prescribed for comorbidities in individuals with dementia. Further, the list was used in a cohort of patients with dementia, to determine theoretically if a reduction in the anticholinergic burden (ACB) could be achieved.
A high prevalence of prescribing potentially inappropriate medications, particularly medications with anticholinergic properties (MAP), has been observed in older adults (>65 years of age) with dementia in New Zealand. MAP have been associated with several adverse outcomes in this vulnerable population, specifically the risk of accelerating cognitive decline in patients with pre-existing dementia.
The purpose of this study was to compile a comprehensive list of therapeutic alternatives to MAP prescribed for comorbidities in individuals with dementia. Further, the list was used in a cohort of patients with dementia, to determine theoretically if a reduction in the anticholinergic burden (ACB) could be achieved.
| Original language | English |
|---|---|
| Publication status | Published - 25 Jun 2021 |
| Event | 255th Otago Medical School Research Society Meeting - PhD Student Speaker Awards - New Zealand, Dunedin, New Zealand Duration: 25 Jun 2021 → 25 Jun 2021 |
Conference
| Conference | 255th Otago Medical School Research Society Meeting - PhD Student Speaker Awards |
|---|---|
| Country/Territory | New Zealand |
| City | Dunedin |
| Period | 25/06/21 → 25/06/21 |